Triple-negative breast cancer is called “triple-negative” because the tumor lacks all three of these receptors. That absence is exactly what makes it more challenging to treat: These targeted forms of ...

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

I was diagnosed with cholangiocarcinoma, or cancer of the bile duct. As far as cancers go, it’s an especially brutal one: The five-year survival rate is around 10 percent, and most people diagnosed ...

In the fall of 2022, when I was 42 and living with my wife and three young kids in a small town in northwest Minnesota, a specialist at an unfamiliar hospital approached us with some test results. He ...

Hoover Institution Senior Fellow Victor Davis Hanson on Wednesday shared an update about his health after doctors removed part of his lung while treating a rare form of cancer. Hanson announced in ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsAmirAli Talasaz - Co-CEO ...

The FDA has faced an extraordinary convergence of political, scientific, legal, and operational pressures over the last year.

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

Barclays 28th Annual Global Healthcare Conference March 11, 2026 10:30 AM EDTCompany ParticipantsSanjiv Patel - ...

Ascentage Pharma will host a Chinese (Mandarin) language investor webcast at 10:00 pm EDT on March 25, 2026 / 10:00 am HKT on March 26, 2026. To access the Chinese language investor event or ...

Trained on 9 trillion DNA base pairs from every domain of life, the Evo 2 model can predict disease-causing mutations, ...

Hantaviruses, transmitted from rodents to people, have a death rate approaching 40%. They're found around the world, and because no approved vaccines ...